Article info
Hepatology
Original research
Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites
- Correspondence to Jun Yu, Institute of Digestive Disease and The Department of Medicine and Therapeutics, Chinese University of Hong Kong, New Territories, Hong Kong; junyu{at}cuhk.edu.hk
Citation
Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites
Publication history
- Received August 19, 2019
- Revised June 4, 2020
- Accepted June 15, 2020
- First published July 21, 2020.
Online issue publication
March 12, 2022
Article Versions
- Previous version (5 March 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.